Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
RRP Defense
|
Veritas (India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.94 % | 2.37 % | 5.71 % |
|
5yr average Equity Multiplier
|
1.87 | 2.69 | 1.75 |
|
5yr Average Asset Turnover Ratio
|
1.12 | 2.19 | 0.63 |
|
5yr Avg Net Profit Margin
|
11.07 % | 2.25 % | 5.19 % |
|
Price to Book
|
3.36 | 410.91 | 0.33 |
|
P/E
|
29.59 | 749.77 | 9.78 |
|
5yr Avg Cash Conversion Cycle
|
37.04 Days | 4.11 Days | 110.26 Days |
|
Inventory Days
|
36.45 Days | 0.06 Days | 5.0 Days |
|
Days Receivable
|
65.7 Days | 13.91 Days | 131.05 Days |
|
Days Payable
|
111.91 Days | 203.03 Days | 97.27 Days |
|
5yr Average Interest Coverage Ratio
|
48.28 | -5.87 | 5.89 |
|
5yr Avg ROCE
|
25.27 % | 7.13 % | 4.98 % |
|
5yr Avg Operating Profit Margin
|
14.8 % | -7.41 % | 6.9 % |
|
5 yr average Debt to Equity
|
0.19 | 0.73 | 0.15 |
|
5yr CAGR Net Profit
|
27.88 % | n/a | 0.74 % |
|
5yr Average Return on Assets
|
12.5 % | 1.2 % | 3.29 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.85 % | 1.85 % | 55.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.24 % | -14.33 % | -8.35 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Remus Pharmaceutical
|
RRP Defense
|
Veritas (India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|